In medical device manufacturing, where stringent standards and regulatory requirements apply, quality control is paramount. This is particularly critical for high-risk medical devices such as coronary stents.

A suitable CDMO partner must not only meet manufacturing specifications but also possess robust engineering capabilities, stringent quality systems, and collaborative synergy to accompany businesses from early-stage development through high-volume commercial production.

A Sirolimus-eluting stent (SES) is a type of drug-eluting coronary stent designed to provide mechanical support inside a coronary artery while delivering a therapeutic drug locally to the vessel wall.